Credit: Shutterstock photoMaxQ AI, a clinical-stage medical device company developing an AI-based medical imaging platform, filed on Thursday with the SEC to raise up to $8 million in an initial public offering.
The Tel Aviv, Israel-based company was founded in 2013 and plans to list on the Nasdaq under the symbol MQAI. MaxQ AI filed confidentially on February 13, 2018. ViewTrade is the sole bookrunner on the deal. No pricing terms were disclosed.
The article AI medical device company MaxQ AI files for a $8 million IPO originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com.
Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital's Renaissance IPO ETF (symbol: IPO) , Renaissance International ETF (symbol: IPOS) , or separately managed institutional accounts may have investments in securities of companies mentioned.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
